Real-World Evidence of Ribociclib Plus Aromatase Inhibitors as First-Line Treatment in Advanced Breast Cancer: The BrasiLEEira Study.
Suzuki DA, Morelle AM, de Brito ML, Paes FR, Mattar A, Leal JHS, Simon SD, Lima EMA, Werutsky G, Piotto GHM, Bines J, Damiani LP, Macedo A, Campos L, Buehler AM.
Suzuki DA, et al. Among authors: simon sd.
JCO Glob Oncol. 2024 Apr;10:e2300484. doi: 10.1200/GO.23.00484.
JCO Glob Oncol. 2024.
PMID: 38603658